Get started
Author

SERGIO PALMERI

Observed names: PALMERI, Sergio, Palmeri S., S PALMERI, S Palmeri, S. PALMERI, S. Palmeri, Sergio Palmeri
Observed institutions: Goethe University Frankfurt, European Organisation for Research and Treatment of Cancer, University of Pavia, Bispebjerg Hospital, Edinburgh Cancer Research, Karolinska Institutet, The Netherlands Cancer Institute, Hospital General Universitario Morales Meseguer, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Federico II University Hospital, Azienda Ospedaliero-Universitaria Cagliari, European Organisation for Research and Treatment of Cancer, Policlinico Universitario di Catania, Ospedale Santa Maria Goretti, Ospedale S.Gennaro, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Hôpital Saint-Louis, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo, Policlinico San Matteo Fondazione, University of Naples Federico II, University of Palermo
OpenAlex ID: A5111909356
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.
1988 · G Ambrosini, M Balli, et al. · Journal of Clinical Oncology · 168
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site
2006 · Sergio Palmeri, Vito Lorusso, et al. · Cancer · 54
PDF
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401
2008 · Pasquale Comella, Bruno Massidda, et al. · Journal of Cancer Research and Clinical Oncology · 51
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial
2005 · P. Comella, B. Massidda, et al. · Annals of Oncology · 48
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)
2006 · P. Comella, G. Filippelli, et al. · Annals of Oncology · 47
PDF
Regulatory Cytokine Gene Polymorphisms and Risk of Colorectal Carcinoma
2006 · ANTONINO CRIVELLO, ANTONIO GIACALONE, et al. · Annals of the New York Academy of Sciences · 45
Cytokine Gene Polymorphisms and Breast Cancer Susceptibility
2006 · LETIZIA SCOLA, MARINA VAGLICA, et al. · Annals of the New York Academy of Sciences · 41
Unknown primary tumors
2011 · C. Natoli, V. Ramazzotti, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 37
Cancer patients as `experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO)
2000 · M. Costantini, E. Mencaglia, et al. · Quality of Life Research · 36
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial
1996 · C. Gridelli, F. Perron, et al. · Annals of Oncology · 33
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer
2005 · On Behalf of the GOCSI Cooperative Group, S De Placido, et al. · British Journal of Cancer · 31
PDF
Should cirrhosis change our attitude towards treating non‐hepatic cancer?
2011 · Giuseppe Cabibbo, Laura Palmeri, et al. · Liver International · 28
PDF
The Combination of Gemcitabine and Vinorelbine is an Active Regimen as Second-Line Therapy in Patients with Metastatic Breast Cancer Pretreated with Taxanes and/or Anthracyclines: a Phase I–II Study
2003 · Alessandro Morabito, Gianfranco Filippelli, et al. · Breast Cancer Research and Treatment · 24
Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group
2002 · P. Comella, E. Crucitta, et al. · Annals of Oncology · 24
Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study
1990 · S Palmeri, V Gebbia, et al. · British Journal of Cancer · 24
PDF
Weekly docetaxel in the treatment of metastatic breast cancer
2008 · Sergio Palmeri · Therapeutics and Clinical Risk Management · 23
PDF
Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen
2001 · V. Gebbia, A. Testa, et al. · Annals of Oncology · 23
PDF
Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study
2005 · S. Palmeri, M. Vaglica, et al. · Oncology · 20
PDF
Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
2010 · L. Bergmann, B. Berns, et al. · Annals of Oncology · 19
Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma
2003 · P Comella, A Farris, et al. · British Journal of Cancer · 19
PDF
Vinorelbine and Cisplatin for the Treatment of Recurrent and/or Metastatic Carcinoma of the Uterine Cervix
2002 · Vittoria Gebbia, Michele Caruso, et al. · Oncology · 18
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial
2001 · S. Palmeri, V. Leonardi, et al. · Lung Cancer · 18
Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report.
2002 · Pietro Citarrella, Vittorio Gebbia, et al. · PubMed · 17
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group
2009 · Pasquale Comella, Vito Lorusso, et al. · Cancer Chemotherapy and Pharmacology · 16
Weekly taxanes in metastatic breast cancer (Review)
2002 · Matteo Zimatore, Marco Danova, et al. · Oncology Reports · 15
Works count: 118
Citation count: 1,224
H-index: 19
I10-index: 37
Year
Topic
Type